← Leaderboards
Keith A. Johnson
Banner Health
$82,231,807
Attributed
$191,123,674
Total exposure
17
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $50M · FY2006–25$50M$37.5M$25M$12.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$221,239,503 · 18
By mechanism
R01$178,783,215 · 9
P01$42,029,288 · 8
R13$427,000 · 1
Top collaborators
- Reisa A. Sperling36 shared
- Paul S. Aisen18 shared
- Bradford C Dickerson5 shared
- Jessica Brooke Langbaum5 shared
- Eric M Reiman5 shared
- Robert C Alexander3 shared
- Adam L Boxer2 shared
- Pierre N. Tariot2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePositron-Emission TomographyAmyloidBrainAmyloid Beta-ProteinTau ProteinsImageParticipantBiological MarkersPathologyImpaired CognitionMagnetic Resonance ImagingCognitiveDepositionNerve DegenerationPre-ClinicalCohortBaseResearch PersonnelAnatomyAmyloid ImagingAging BrainSampling
Grant awards (86)
The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) Study$6,467,513
R01 · FY2025 · AG
API A4 Alzheimer's Prevention Trial$4,136,602
R01 · FY2025 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$3,556,723
P01 · FY2025 · AG
Imaging Core (Core C)$1,024,903
P01 · FY2025 · AG · contact PI
Temporal sequence, anatomic progression, and interaction of amyloid-beta and tau (Project 1)$216,150
P01 · FY2025 · AG · contact PI
The Alzheimer's Disease Tau Platform Clinical Trial$29,813,375
R01 · FY2024 · AG
Combination anti-amyloid therapy for preclinical Alzheimer's disease$8,720,510
R01 · FY2024 · AG
API A4 Alzheimer's Prevention Trial$6,538,660
R01 · FY2024 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$3,629,309
P01 · FY2024 · AG
Imaging Core (Core C)$1,055,470
P01 · FY2024 · AG · contact PI
Temporal sequence, anatomic progression, and interaction of amyloid-beta and tau (Project 1)$222,597
P01 · FY2024 · AG · contact PI
The Alzheimer's Disease Tau Platform Clinical Trial$30,887,229
R01 · FY2023 · AG
Combination anti-amyloid therapy for preclinical Alzheimer's disease$8,723,068
R01 · FY2023 · AG
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$3,979,320
R01 · FY2023 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$3,491,054
P01 · FY2023 · AG
Imaging Core (Core C)$1,055,470
P01 · FY2023 · AG · contact PI
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$328,079
R01 · FY2023 · AG
Temporal sequence, anatomic progression, and interaction of amyloid-beta and tau (Project 1)$222,596
P01 · FY2023 · AG · contact PI
Combination anti-amyloid therapy for preclinical Alzheimer's disease$8,727,018
R01 · FY2022 · AG
API A4 Alzheimer's Prevention Trial$8,413,794
R01 · FY2022 · AG
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$4,308,552
R01 · FY2022 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$3,455,408
P01 · FY2022 · AG
Imaging Core (Core C)$988,318
P01 · FY2022 · AG · contact PI
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$341,233
R01 · FY2022 · AG
Temporal sequence, anatomic progression, and interaction of amyloid-beta and tau (Project 1)$238,731
P01 · FY2022 · AG · contact PI
Combination anti-amyloid therapy for preclinical Alzheimer's disease$8,732,454
R01 · FY2021 · AG
API A4 Alzheimer's Prevention Trial$7,162,340
R01 · FY2021 · AG
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$3,980,365
R01 · FY2021 · AG
Human Amyloid Imaging (HAI) Meeting$49,800
R13 · FY2021 · AG · contact PI
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$3,308,596
P01 · FY2020 · AG
Imaging Core (Core C)$1,055,470
P01 · FY2020 · AG · contact PI
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2020 · DC
Temporal sequence, anatomic progression, and interaction of amyloid-beta and tau (Project 1)$222,597
P01 · FY2020 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$49,800
R13 · FY2020 · AG · contact PI
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$3,981,411
R01 · FY2019 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$2,689,773
P01 · FY2019 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2019 · DC
Core C: Imaging Core$750,537
P01 · FY2019 · AG · contact PI
Project 1: PET Measures of Tau and Amyloid Pathology$229,258
P01 · FY2019 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$49,800
R13 · FY2019 · AG · contact PI
Combination anti-amyloid therapy for preclinical Alzheimer's disease$9,021,816
R01 · FY2018 · AG
API A4 Alzheimer's Prevention Trial$5,670,134
R01 · FY2018 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$2,234,180
P01 · FY2018 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2018 · DC
Disentangling the contribution of tau to aging and AD$712,125
R01 · FY2018 · AG · contact PI
Core C: Imaging Core$673,475
P01 · FY2018 · AG · contact PI
Disentangling the contribution of tau to aging and AD$421,250
R01 · FY2018 · AG · contact PI
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$356,123
P01 · FY2018 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$224,361
P01 · FY2018 · AG
Project 1: PET Measures of Tau and Amyloid Pathology$187,582
P01 · FY2018 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$49,800
R13 · FY2018 · AG · contact PI
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$2,411,664
P01 · FY2017 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2017 · DC
Core C: Imaging Core$727,677
P01 · FY2017 · AG · contact PI
Disentangling the contribution of tau to aging and AD$712,125
R01 · FY2017 · AG · contact PI
Project 1: PET Measures of Tau and Amyloid Pathology$204,041
P01 · FY2017 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$49,800
R13 · FY2017 · AG · contact PI
The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease$4,020,661
R01 · FY2016 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$2,275,025
P01 · FY2016 · AG
Imaging tau, amyloid, and neurodegeneration in PPA$854,998
R01 · FY2016 · DC
Core C: Imaging Core$770,841
P01 · FY2016 · AG · contact PI
Disentangling the contribution of tau to aging and AD$712,125
R01 · FY2016 · AG · contact PI
Evolution of memory related fMRI activation over the course of MCI and AD$687,064
R01 · FY2016 · AG
Project 1: PET Measures of Tau and Amyloid Pathology$181,811
P01 · FY2016 · AG · contact PI
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$138,510
P01 · FY2016 · AG
Human Amyloid Imaging (HAI) Meeting$35,000
R13 · FY2016 · AG · contact PI
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study$2,345,103
P01 · FY2015 · AG
Core C: Imaging Core$807,861
P01 · FY2015 · AG · contact PI
Disentangling the contribution of tau to aging and AD$690,760
R01 · FY2015 · AG · contact PI
Evolution of memory related fMRI activation over the course of MCI and AD$666,452
R01 · FY2015 · AG
Project 1: PET Measures of Tau and Amyloid Pathology$181,811
P01 · FY2015 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$35,000
R13 · FY2015 · AG · contact PI
Disentangling the contribution of tau to aging and AD$712,125
R01 · FY2014 · AG · contact PI
Evolution of memory related fMRI activation over the course of MCI and AD$686,405
R01 · FY2014 · AG
Characterizing the Evolution of Amyloid Deposition in Normal Elderly$595,563
R01 · FY2014 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$35,000
R13 · FY2014 · AG · contact PI
Evolution of memory related fMRI activation over the course of MCI and AD$653,300
R01 · FY2013 · AG
Characterizing the Evolution of Amyloid Deposition in Normal Elderly$582,979
R01 · FY2013 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$35,000
R13 · FY2013 · AG · contact PI
Evolution of memory related fMRI activation over the course of MCI and AD$725,116
R01 · FY2012 · AG
Characterizing the Evolution of Amyloid Deposition in Normal Elderly$639,328
R01 · FY2012 · AG · contact PI
Human Amyloid Imaging (HAI) Meeting$38,000
R13 · FY2012 · AG · contact PI
Characterizing the Evolution of Amyloid Deposition in Normal Elderly$662,861
R01 · FY2011 · AG · contact PI
Characterizing the Evolution of Amyloid Deposition in Normal Elderly$694,513
R01 · FY2010 · AG · contact PI
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)$505,010
P01 · FY2006 · AG · contact PI
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)$391,253
P01 · FY2002 · AG